Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome.

Joseph S DillonMatthew H KulkeDieter HörschLowell B AnthonyRichard R P WarnerEmily BergslandStaffan WelinThomas M O'DorisioPamela L KunzChad McKeePablo LapuertaPhillip BanksMarianne Pavel

Published in: Journal of gastrointestinal cancer (2021)

ClinicalTrials.gov Identifiers: NCT01677910, NCT02063659.

Keyphrases

phase iii
open label
clinical trial
double blind
phase ii
placebo controlled
case control
ionic liquid
case report